Integra Lifesciences Holdings (IART) Consolidated Net Income (2009 - 2026)

Integra Lifesciences Holdings' Consolidated Net Income history runs 17 years deep, the most recent figure standing at -$4.6 million for Q1 2026.

• In Q1 2026, Consolidated Net Income rose 81.75% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$495.8 million (down 1612.31% YoY), while the FY2025 annual figure was -$516.5 million, down 7337.7% from the prior year.
• Consolidated Net Income came in at -$4.6 million for Q1 2026 at Integra Lifesciences Holdings, down from -$1.7 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $52.9 million in Q4 2022 to a low of -$484.1 million in Q2 2025.
• A 5-year average of -$16.5 million and a median of $4.2 million in 2023 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income sank 3803.18% in 2025 and surged 81.75% in 2026, its largest moves.
• Integra Lifesciences Holdings' Consolidated Net Income stood at $52.9 million in 2022, then tumbled by 62.54% to $19.8 million in 2023, then slipped by 2.01% to $19.4 million in 2024, then plunged by 108.77% to -$1.7 million in 2025, then plunged by 170.95% to -$4.6 million in 2026.
• According to Business Quant data, Consolidated Net Income over the past three periods registered -$4.6 million, -$1.7 million, and -$5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison